High prevalence of esophageal dysmotility in asymptomatic obese patients

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 6, 2014, Pages 311-314

  Côté Daigneault, Justin ^a   Leclerc, Pierre ^a   Joubert, Josette ^a   Bouin, Mickael ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bariatric surgery; Esophageal manometry; Obesity

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; COMORBIDITY; DYSPEPSIA; DYSPHAGIA; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS PRESSURE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MANOMETRY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THORAX PAIN; COMPLICATION; ESOPHAGEAL MOTILITY DISORDERS; MORBID OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUEBEC; REGISTER; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

ADULT; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MANOMETRY; OBESITY, MORBID; PREVALENCE; PROSPECTIVE STUDIES; QUEBEC; REGISTRIES; RISK FACTORS;

EID: 84902684689     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/960520     Document Type: Article

References (27)

1. World Health Organization (WHO).〈www.who.int/topics/obesity/en〉 (Accessed November 2, 2013).
2. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008;207:928-34.
3. Collaboration PS; Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. 2009;373:1083-96.
4. Jaffin BW, Knoepflmacher P, Greenstein R. High prevalence of asymptomatic motility disorders among morbidly obese patients. Obesity 1999;9:390-5. (Pubitemid 29383343)
5. Koppman JS, Poggi L, Szomstein S, et al. Esophageal motility disorders in the morbidly obese population. Surg Endosc 2007;21:761-4. (Pubitemid 46675505)
6. Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 2004;14:959-66. (Pubitemid 39093471)
7. Zhao J, Frøkjaer JB, Drewes AM, et al. Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J Gastroenterol 2006;12:2846-57. (Pubitemid 43805453)
8. Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Gastroenterol Clinics N Am 2010;39:39-46.
9. Fisichella PM, Patti MG. Gastroesophageal reflux disease and morbid obesity: Is there a relation? World J Surg 2009;33:2034-8.
10. Roth J, Qiang X, Marbán SL, et al. The obesity pandemic: Where have we been and where are we going? Obes Res 2004;(12 Suppl 2):88S-101S.
11. Favretti F, Ashton D, Busetto L, et al. The gastric band: First-choice procedure for obesity surgery. World J Surg 2009;33:2039-48.
12. O'Brien PE, Dixon JB, Brown W. Obesity is a surgical disease: Overview of obesity and bariatric surgery. ANZ J Surg 2004;74:200-4. (Pubitemid 38621657)
13. Chan JL, Mun EC, Stoyneva V, et al. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 2006;14:194-8. (Pubitemid 46214749)
14. Prachand VN, Alverdy JC. The role of malabsorption in bariatric surgery. World J Surg 2009;33:1989-94.
15. Burton PR, Brown W, Laurie C, et al. Outcomes, satiety, and adverse upper gastrointestinal symptoms following laparoscopic adjustable gastric banding. Obes Surg 2011;21:574-81.
16. Roller JE, Provost DA. Revision of failed gastric restrictive operations to Roux-en-Y gastric bypass: Impact of multiple prior bariatric operations on outcome. Obes Surg 2006;16:865-9. (Pubitemid 44133474)
17. Suter M, Giusti V, Calmes JM, Paroz A. Preoperative upper gastrointestinal testing can help predicting long-term outcome after gastric banding for morbid obesity. Obes Surg 2008;18:578-82.
18. Klaus A, Weiss H. Is preoperative manometry in restrictive bariatric procedures necessary? Obes Surg 2008;18:1039-42.
19. American Gastroenterological Association Clinical Practice Committee, AGA Technical Review on the Clinical Use of Esophageal Manometry. Gastroenterology 2005;128:209-24.
20. Leite LP, Johnston BT, Barrett J, et al. Ineffective esophageal motility (IEM): The primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997;42:1859-65. (Pubitemid 27433533)
21. Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci 1987;32:583-92. (Pubitemid 17084874)
22. Quiroga E, Flum D, Dellinger EP, Oelschlager BK. Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: Evaluation with multichannel intraluminal impedance. Surg Endosc 2006:739-43. (Pubitemid 43978771)
23. Yarandi SS, Hebbar G, Sauer CG, et al. Diverse roles of leptin in the gastrointestinal tract: Modulation of motility, absorption, growth, and inflammation. Nutrition (Burbank) 2011;27:269-75.
24. Hata N, Murata S, Maeda J, et al. Predictors of gastric myoelectrical activity in type 2 diabetes mellitus. J Clin Gastroenterol 2009;43:429-36.
25. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-6.
26. Saad MF, Riad-Gabriel MG, Khan A, et al. Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity. J Clin Endocrinol Metab 1998;83:453.
27. Küper MA, Kramer KM, Kirschniak A, et al. Dysfunction of the lower esophageal sphincter and dysmotility of the tubular esophagus in morbidly obese patients. Obes Surg 2009;19:1143-9.